A PROSPECTIVE TRIAL OF 5-FU AND BCNU IN THE TREATMENT OF ADVANCED GASTRIC CANCER
- 1 February 1981
- journal article
- research article
- Published by Wiley in Anz Journal of Surgery
- Vol. 51 (1) , 16-19
- https://doi.org/10.1111/j.1445-2197.1981.tb05895.x
Abstract
The efficacy of a combination of 5-FU [5-fluorouracil] and BCNU [1-bis-2-chloroethyl-1-nitrosourea] in the treatment of advanced gastric cancer was studied. Patients whose cancer was recurrent following surgery or in whom surgery was deemed inappropriate were entered in the study and given the 2-drug combination at 6 wk intervals until death or clear progression of disease occurred. Of twenty-eight patients had unequivocal regression of their disease. The early optimism for this form of therapy in advanced gastric cancer is not supported by this study.This publication has 8 references indexed in Scilit:
- Improved combination chemotherapy in advanced gastric cancer.BMJ, 1979
- Chemotherapy of Gastrointestinal CancerClinics in Gastroenterology, 1976
- Cancer of the stomach: A review of 854 patientsBritish Journal of Surgery, 1976
- A review of chemotherapy in gastric cancerCancer, 1974
- A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancerCancer, 1974
- Pathology and prognosis of carcinoma of the stomachBritish Journal of Surgery, 1970
- Type of Mastectomy in Cancer of the BreastAnnals of Surgery, 1966
- Carcinoma of the Stomach: a 10-year Survey of Results and of Factors Affecting PrognosisBMJ, 1965